TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5746.61M
Enterprise Value 3695.35M
Trailing P/E N/A
Forward P/E 1-4.48
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)4,899.61
Price/Book (mrq)6.82
Enterprise Value/Revenue 34,563.25
Enterprise Value/EBITDA 6-4.68

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-97,480.49%

Management Effectiveness

Return on Assets (ttm)-76.75%
Return on Equity (ttm)-165.11%

Income Statement

Revenue (ttm)152.38k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)152.38k
EBITDA -148.46M
Net Income Avi to Common (ttm)-148.07M
Diluted EPS (ttm)-2.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)126.25M
Total Cash Per Share (mrq)1.65
Total Debt (mrq)210k
Total Debt/Equity (mrq)0.21
Current Ratio (mrq)3.68
Book Value Per Share (mrq)1.33

Cash Flow Statement

Operating Cash Flow (ttm)-106.86M
Levered Free Cash Flow (ttm)-51.79M

Trading Information

Stock Price History

Beta 1.84
52-Week Change 3-24.15%
S&P500 52-Week Change 316.29%
52 Week High 317.35
52 Week Low 37.25
50-Day Moving Average 311.66
200-Day Moving Average 313.30

Share Statistics

Avg Vol (3 month) 31.09M
Avg Vol (10 day) 31.48M
Shares Outstanding 582.5M
Float 53.65M
% Held by Insiders 112.03%
% Held by Institutions 156.37%
Shares Short (Aug 31, 2018) 49.95M
Short Ratio (Aug 31, 2018) 410.64
Short % of Float (Aug 31, 2018) 415.08%
Short % of Shares Outstanding (Aug 31, 2018) 412.01%
Shares Short (prior month Jul 31, 2018) 49.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/5625
Last Split Date 3Apr 30, 2012